Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Net Income/ Starting Line | 727.23 | 747.22 | 972.55 | 657.33 |
Depreciation/ Depletion | 312.41 | 260.12 | 244.86 | 323.31 |
Non- Cash Items | 237.74 | 233.65 | 167.76 | 274.95 |
Changesin Working Capital | -180.14 | -494.13 | -402.84 | -551.15 |
Cashfrom Operating Activities | 1,097.24 | 746.85 | 982.33 | 704.44 |
Capital Expenditures | -307.13 | -403.36 | -396.99 | -145.67 |
Other Investing Cash Flow Items Total | -405.38 | -64.32 | -391.80 | -106.18 |
Cashfrom Investing Activities | -712.51 | -467.69 | -788.79 | -251.85 |
Financing Cash Flow Items | -290.86 | -222.92 | -217.77 | -213.47 |
Issuance( Retirement)of Stock Net | 7.66 | - | - | - |
Issuance( Retirement)of Debt Net | 119.00 | 77.52 | 65.92 | 24.57 |
Cashfrom Financing Activities | -164.21 | -145.40 | -151.85 | -188.90 |
Foreign Exchange Effects | -2.00 | -0.13 | 0.19 | -4.62 |
Net Changein Cash | 218.52 | 133.64 | 41.87 | 259.07 |
Cash Interest Paid | 208.18 | 178.56 | 155.32 | 184.48 |
Cash Taxes Paid | 223.65 | 200.48 | 311.18 | 200.43 |
Emcure Pharmaceuticals Dividend Emcure Pharmaceuticals Bonus Emcure Pharmaceuticals News Emcure Pharmaceuticals AGM Emcure Pharmaceuticals Rights Emcure Pharmaceuticals Splits Emcure Pharmaceuticals Board Meetings Emcure Pharmaceuticals Key Metrics Emcure Pharmaceuticals Shareholdings Emcure Pharmaceuticals Profit Loss Emcure Pharmaceuticals Balance Sheet Emcure Pharmaceuticals Q1 Results Emcure Pharmaceuticals Q2 Results Emcure Pharmaceuticals Q3 Results Emcure Pharmaceuticals Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks